Grant: Discovery Grants Program - Individual
University of British Columbia
$20,000.00
Weak chemical interactions and their significance in structure and reactivity
FY 2015-16
Summary
<span style=""font-size: 12.7272720336914px; line-height: 19.2000007629395px;"">Halogen bonding (XB) is a relatively new mode of weak chemical bonding. It differs from hydrogen bonding (HB) in many aspects and has thus been used as an alternative in a number of areas including pharmaceuticals and materials chemistry. However, the details of XB have still not been completely elucidated and the nature of XB is still controversial.
<span style=""font-size: 12.7272720336914px; line-height: 1.5em;"">We have recently developed a methodology for quantifying the degree of covalency in XB species using X-ray spectroscopies, allowing us an unprecedented opportunity to develop a quantitative picture of the factors that affect XB. The covalency of such interactions will dictate the degree to which XB interactions can be used to activate molecules for reactivity and their utility in a wide range of chemical applications. <span style=""font-size: 12.7272720336914px; line-height: 1.5em;"">The main objectives of this research proposal are to probe the nature of XB in relatively simple and controlled environments using our recently developed approach. To provide additional details, we will explore the nature of XB using a broad range of spectroscopic tools in order to identify a spectroscopic 'fingerprint' that can be used to readily identify and quantify XB in more complex systems. This will allow us to develop and investigate XB-based pharmaceuticals that disrupt the formation of protein aggregates linked to devastating diseases such as Alzheimer's, Amyotrophic Lateral Schlerosis (ALS), and Parkinson's disease.
<span style=""font-size: 12.7272720336914px; line-height: 1.5em;""><span style=""font-size: 12.7272720336914px; line-height: 1.5em;"">Our systematic approach to the elucidation of XB will also be applied to other systems where the nature of weak bonding is crucial in determining their chemical behaviour. Most notably, we will probe the nature of late transition metal-alkene bonds, which are ubiquitous in catalysis, but are not well understood. Improved understanding has major implications for the development of new catalysts.
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2015-05050
Name nom
Kennepohl, Pierre
Department département
Chemistry - Chemistry
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
20000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1208
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Materials sciences
Area of application fr
Sciences des matériaux
Research subject code
3601
Research subject group en
Inorganic chemistry
Research subject group fr
Chimie inorganique
Research subject en
Inorganic nonmetal chemistry
Research subject fr
Chimie inorganique -- non métaux
Partie
1
Nb partie
1
Application title
Weak chemical interactions and their significance in structure and reactivity
Keyword
NSERC
Application summary
<p><span style=""font-size: 12.7272720336914px; line-height: 19.2000007629395px;"">Halogen bonding (XB) is a relatively new mode of weak chemical bonding. It differs from hydrogen bonding (HB) in many aspects and has thus been used as an alternative in a number of areas including pharmaceuticals and materials chemistry. However, the details of XB have still not been completely elucidated and the nature of XB is still controversial.</span></p>
<p><span style=""font-size: 12.7272720336914px; line-height: 1.5em;"">We have recently developed a methodology for quantifying the degree of covalency in XB species using X-ray spectroscopies, allowing us an unprecedented opportunity to develop a quantitative picture of the factors that affect XB. The covalency of such interactions will dictate the degree to which XB interactions can be used to activate molecules for reactivity and their utility in a wide range of chemical applications. </span><span style=""font-size: 12.7272720336914px; line-height: 1.5em;"">The main objectives of this research proposal are to probe the nature of XB in relatively simple and controlled environments using our recently developed approach. To provide additional details, we will explore the nature of XB using a broad range of spectroscopic tools in order to identify a spectroscopic 'fingerprint' that can be used to readily identify and quantify XB in more complex systems. This will allow us to develop and investigate XB-based pharmaceuticals that disrupt the formation of protein aggregates linked to devastating diseases such as Alzheimer's, Amyotrophic Lateral Schlerosis (ALS), and Parkinson's disease.</span></p>
<p><span style=""font-size: 12.7272720336914px; line-height: 1.5em;""></span><span style=""font-size: 12.7272720336914px; line-height: 1.5em;"">Our systematic approach to the elucidation of XB will also be applied to other systems where the nature of weak bonding is crucial in determining their chemical behaviour. Most notably, we will probe the nature of late transition metal-alkene bonds, which are ubiquitous in catalysis, but are not well understood. Improved understanding has major implications for the development of new catalysts.</span></p>